PDS Biotechnology
PDSB
PDSB
31 hedge funds and large institutions have $2.83M invested in PDS Biotechnology in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-6
Holders Change %
-16.22%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
6
Closed
11
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
+$15K
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| $103 | – | – | – |
|
|
GTC
27
Ghost Tree Capital
New York
| – | -$820K | -50,000 | Closed |
|
28
Goldman Sachs
New York
| – | -$88K | -5,344 | Closed |
|
|
AAMU
29
Amundi Asset Management US
Boston,
Massachusetts
| – | -$64K | -3,920 | Closed |
|
30
Millennium Management
New York
| – | -$52K | -3,189 | Closed |
|
|
ARTA
31
A.R.T. Advisors
New York
| – | -$33K | -2,043 | Closed |
|
|
ECM
32
Element Capital Management
New York
| – | -$32K | -1,933 | Closed |
|
33
UBS Group
Zurich,
Switzerland
| – | -$25K | -1,545 | Closed |
|
34
Jane Street
New York
| – | -$17K | -1,024 | Closed |
|
|
BCM
35
BlueCrest Capital Management
St Helier,
Jersey
| – | -$11K | -655 | Closed |
|